FindTrial
Sign In

A Comparative Study of New Molecular Markers for prognosis in acute leukemia patients

A Comparative Study of New Molecular Markers for prognosis in acute leukemia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-14004612
Enrollment
Unknown
Registered
2014-03-11
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute leukemia

Interventions

chemotherapy group:Molecular genetic sequencing
transplantation:Molecular genetic sequencing

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 years and more; 2. Patients who were diagnosed with acute leukemia and be able to receive high-dose/medium-dose chemotherapy or allo-hematopoietic stem cell transplantation; 3. To be able to and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Enrolled in other clinical trials now or within 30 days before; 2. Pregnant or lactating females; 3. Unsuitable to enter this trial by researchers' judgement.

Design outcomes

Primary

MeasureTime frame
Leukemia Free Survival;Overall Survival;Relapse Incidence;—

Countries

China

Contacts

Public ContactDepei Wu

The First Affiliated Hospital of Soochow University

wudepei@medmail.com.cn+86 0512 67781856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026